NEW YORK (AP) -- Shares of Medicis Pharmaceutical Corp. fell Thursday as potential generic competition to its acne treatment Solodyne continues to worry investors and a weakened economy poses a threat to future wrinkle treatment sales.
NEW YORK (AP) -- Shares of Medicis Pharmaceutical Corp. fell Thursday as potential generic competition to its acne treatment Solodyne continues to worry investors and a weakened economy poses a threat to future wrinkle treatment sales.
